New test may predict which lung cancer treatments work best
NCT ID NCT07262671
First seen Jan 09, 2026 · Last updated Jun 23, 2026 · Updated 24 times
Summary
This study is testing whether tiny particles called exosomes, found in blood and lung fluid, can predict how well treatment works in people with advanced non-small cell lung cancer. Researchers will collect samples from 100 patients before and during standard therapy. The goal is to see if exosome RNA patterns can tell doctors early on whether a treatment is working.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (ADVANCED NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Cancer hospital of Fudan University
Shanghai, Shanghai Municipality, 200032, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test that helps doctors choose the best treatment for advanced lung cancer patients.
What could go wrong
This is an early observational study, not a treatment trial. It may not find a clear link, and results may not apply to all patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.